A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes
Clinical trial NCT07026968 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07026968
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2026-10-30
- Enrollment
- 815
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.